Amondys45.com

Keyword Suggestion

Amondys 45

Amondys45 dose

Amondys 45 casimersen

Domain Informations

Whois Informations
Top 10 Domain Provider

Amondys45.com lookup results from whois.corporatedomains.com server:

Network

Owner

Technical support

Abuse

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 64.68.200.48

Fetching Web Sites Hosted

Site Inspections

Port Scanner (IP: 64.68.200.48)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 64.68.200.48)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with amondys45.com

Found 0 emails of this domain

Recent Searched Sites

› Justalk.ru (1 seconds ago) / RU

› Nester-house.com.ua (1 seconds ago) / US

› Epicycloidengr.com (1 seconds ago) / US

› Magic-tricks.ru (21 seconds ago) / RU

› Amondys45.com (1 seconds ago) / CA

› Blackburn.gov.uk (12 seconds ago) / GB

› Odlub.com (6 seconds ago) / US

› 000618.ipo.hk (3 seconds ago) / CN

› 06.imls.ru (4 seconds ago) / RU

› Eyesofsanantonio.com (10 seconds ago) / US

› Quantumpace.com (9 seconds ago) / US

› Revolutionrace.no (15 seconds ago) / US

› Wahooart.com (7 seconds ago) / CA

› Backinjob.de (8 seconds ago) / DE

› Bcheck.cl (4 seconds ago) / US

› Privatearchive.club (8 seconds ago) / AU

› Luottolaskuri.fi (9 seconds ago) / US

› Fiercecottage.com (3 seconds ago) / US

› Riverfallsdentistry.com (6 seconds ago) / US

› Buyfleetnow.com (14 seconds ago) / US

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with amondys45.com on Search Engine

HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE …

FULL PRESCRIBING INFORMATION. 1 INDICATIONS AND USAGE AMONDYS 45 is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping. This indication is approved under accelerated approval based on an increase in dystrophin

Amondys45.com

Amondys 45 (Casimersen Injection): Uses, Dosage, Side …

2021-07-22 · AMONDYS 45 (casimersen) injection is a sterile, aqueous, preservative-free, concentrated solution for dilution prior to intravenous administration. AMONDYS 45 is a clear to slightly opalescent, colorless liquid and may contain trace amounts of small, white to off-white amorphous particles. AMONDYS 45 is supplied in single-dose vials containing ...

Rxlist.com

Amondys-45 Intravenous: Uses, Side Effects, Interactions …

How to use Amondys-45 50 Mg/Ml Intravenous Solution Duchenne Muscular Dystrophy-Exon Skipping Antisense Oligonuc. This medication is given by injection into a vein by a health care professional as ...

Webmd.com

Amondys45(Casimersen)治疗杜氏肌营养不良症获FDA批准

2021-03-01 · Amondys45(Casimersen) 什么是杜氏肌营养不良. 杜氏肌营养不良（DMD）是一种罕见的致命性神经肌肉遗传病，全世界每3500-5000名男性中就有一人发生。DMD是由编码肌营养不良蛋白的基因中的改变或突变引起的。 DMD的症状通常出现在婴幼儿身上。受影响的儿童可能 …

Zhuanlan.zhihu.com

Amondys45(Casimersen)治疗杜氏肌营养不良症获FDA批准

2021-03-01 · Amondys45 (Casimersen)治疗杜氏肌营养不良症获FDA批准. 2021年02月25日， Sarepta Therapeutics公司宣布美国FDA已批准该公司开发的反义寡核苷酸疗法Amondys 45（casimersen）上市，用于治疗外显子45跳跃基因突变的杜氏肌营养不良症（DMD）患者。. Amondys 45成为继Exondys 51 (eteplirsen ...

Sohu.com

Duchenne population potentially amenable to exon skipping

12-44 18-44 Exon 51 Skip-amenable 3-50 4-50 5-50 6-50 9-50 10-50 11-50 13-50 14-50 15-50 16-50 17-50 19-50

Cureduchenne.org

Casimersen (Amondys-45) | BCBSND

2021-03-15 · Description. Casimersen (Amondys-45) is an antisense oligonucleotide designed to bind to exon 45 of dystrophin pre-mRNA resulting in exclusion of this exon during mRNA processing in individuals with genetic mutations that are amenable to exon 45 skipping. Exon 45 skipping is intended to allow for production of an internally truncated dystrophin ...

Bcbsnd.com

SareptAssist | Sarepta Therapeutics

Our team is here to help your patients navigate the process of starting and staying on therapy. Get your patients started in three steps: Download the Start Form. Fill out the Start Form and Fax it to 1-800-621-5203. A dedicated Case Manager will contact your patient soon.

Sarepta.com

杜氏肌营养不良症新药Amondys 45（casimersen）注射剂说明书

2022-05-27 · 香港济民药业提供Amondys 45的价格,同时包括Amondys 45说明书,Amondys 45功效与作用,Amondys 45副作用,Amondys 45哪里有卖等信息,为您使用和购买Amondys 45提供最有价 …

Pidrug.com

casimersen (Amondys 45 TM Place of Service Office Administration ...

**CRITERIA FOR HOSPITAL OUTPATIENT FACILITY ADMINISTRATION ** AAAAI Guidelines 2011, MCG™ Care Guidelines, 19th edition, 2015. Members with the following plans: PPO, Direct Contract HMO, and when applicable , ASO/Shared Advantage/HMO (non-direct contract) may be required to have their medication administered at a preferred site of service, including the …

Blueshieldca.com

Amondys45 Archives – Info Farmasi Terkini Berbasis Ilmiah dan …

Info Farmasi Terkini Berbasis Ilmiah dan Praktis Majalah Farmasi Online Pertama di Indonesia

Farmasetika.com

MH MRx Amondys45 10 21

MH_MRx_Amondys45_10_21.docx Author: Comm & Doc Mgmt Created Date: 2/10/2022 12:45:26 PM ...

Specialtydrug.magellanprovider.com

Amondys 45 (casimersen) dosing, indications, interactions

Mechanism of Action. Antisense oligonucleotide of the phosphorodiamidate morpholino oligomer (PMO) subclass. PMO binds to exon 45 of dystrophin pre-mRNA, resulting in exclusion of this exon during mRNA processing in patients with genetic mutations that are amenable to exon 53 skipping. Exon 45 skipping is intended to allow for production of an ...

Reference.medscape.com

amondys.org domain info (Am On Dys)

A website for this domain is hosted in United States, according to the geolocation of its IP address 165.160.15.20 and 165.160.13.20.

Domain-status.com

CureDuchenne | Funding research to find a cure for Duchenne

2021-06-21 · VTA-1100. Preclinical. * Discontinued means Discontinued at the clinical stage. Last Updated 6/21/2021. You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.

Cureduchenne.org

amondys.us domain datasheet - domain-status.com

A website for this domain is hosted in United States, according to the geolocation of its IP address 165.160.15.20 and 165.160.13.20.

Domain-status.com

Custom Mayo MRx Amondys45 10 21 - Magellan Provider

Page 4 | AMONDYS 45™ (casimersen) Prior Auth Criteria Proprietary Information. Restricted Access – Do not disseminate or copy without approval.

Specialtydrug.magellanprovider.com

Gene, Cell, & RNA Therapy Landscape

Amondys45 casimersen 2021 Dystrophy, Duchenne muscular US Sarepta Therapeutics Nulibry fosdenopterin 2021 Molybdenum cofactor deficiency US Orphatec Lagevrio molnupiravir 2021 Infection, coronavirus, novel coronavirus US, UK, Denmark, Ireland, India, Japan, Mexico, Morocco, Indonesia, Australia, South Korea Ridgeback Biotherapeutics Text highlighted in …

Asgct.org

Amondys 45 ( Exondys 51 ( Viltepso (viltolarsen Vyondys 53

Amondys 45 (casimersen)Exondys 51 (eteplirsen) Viltepso (viltolarsen) Vyondys 53 (golodirsen) PHYSICIAN INFORMATION PATIENT INFORMATION * Physician Name:

Static.cigna.com

2021盘点：FDA批准创新疗法沿着肿瘤、罕见病和慢病领域极速前进

2021-12-29 · 2021年4月23日，FDA批准Zynlonta (loncastuximab tesirine-lpyl)上市，用于治疗已接受过2种或多种系统疗法的复发或难治性 (r/r)大B细胞淋巴瘤 (LBCL)成人患者。. Zynlonta是首个靶向CD19的抗体偶联药物。. CD19是一个经验证的治疗B细胞恶性肿瘤的热门靶点。. Zynlonta的活 …

Mybiogate.com

Domains Expiration Date Updated

Site	Provider	Expiration Date
hashdex.com	godaddy.com	3 Years, 189 Days
portal42.us	key-systems.net	-2 Years, -45 Days
cietac-eu.org	ionos.com	-2 Years, -140 Days
iclas.org	ascio.com	-2 Years, -123 Days
iamed.com	godaddy.com	-2 Years, -81 Days
condoor.com	key-systems.net	-1 Years, -344 Days
bizfire-directory.com	godaddy.com	-1 Years, -340 Days
upbam.org	name.com	-1 Years, -263 Days
fierohub.com	inleed.com	89 Days
gayegg.com	gmo.jp	-2 Years, -159 Days

Browser All